Complement Factor D Inhibitor [EPC]

Complement Factor D Inhibitor [EPC] was reported 310 times

Drugs of the Complement Factor D Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VASCULAR ACCESS SITE INJURY 1 0.1250
1 BREAKTHROUGH HAEMOLYSIS 23 0.0576
2 EXTRAVASCULAR HAEMOLYSIS 20 0.0471
3 TRACHEAL COMPRESSION 1 0.0217
4 INCISION SITE RASH 1 0.0167
5 BLOOD COPPER DECREASED 1 0.0122
6 HAPTOGLOBIN ABNORMAL 1 0.0109
7 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 4 0.0085
8 TYPE III IMMUNE COMPLEX MEDIATED REACTION 4 0.0072
9 MENINGOCOCCAL INFECTION 2 0.0063
10 RETICULOCYTE COUNT INCREASED 5 0.0062
11 BLOOD FOLATE INCREASED 1 0.0060
12 HAEMODIALYSIS COMPLICATION 1 0.0059
13 THALASSAEMIA 1 0.0058
14 INTRAVASCULAR HAEMOLYSIS 3 0.0054
15 HAEMOGLOBINURIA 5 0.0045
16 HAPTOGLOBIN DECREASED 3 0.0037
17 DISEASE SUSCEPTIBILITY 1 0.0036
18 HAEMOLYSIS 28 0.0036
19 MERYCISM 1 0.0035
20 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
21 RETICULOCYTE COUNT DECREASED 1 0.0023
22 RENAL STONE REMOVAL 1 0.0018
23 BLOOD BILIRUBIN DECREASED 1 0.0016
24 OESOPHAGEAL ACHALASIA 1 0.0016
25 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
26 CRITICAL ILLNESS 1 0.0013
27 RENAL ABSCESS 1 0.0012
28 MEAN CELL VOLUME INCREASED 3 0.0012
29 BLOOD IRON INCREASED 2 0.0011
30 MYELOFIBROSIS 3 0.0010
31 INNER EAR DISORDER 1 0.0009
32 APLASTIC ANAEMIA 4 0.0008
33 BILIARY TRACT DISORDER 1 0.0007
34 PANCREATIC ENZYMES INCREASED 1 0.0007
35 INTELLECTUAL DISABILITY 1 0.0007
36 NON-CARDIAC CHEST PAIN 2 0.0006
37 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
38 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
39 NARCOLEPSY 1 0.0005
40 BONE MARROW TRANSPLANT 1 0.0005
41 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
42 HAEMOGLOBIN ABNORMAL 3 0.0005
43 INFECTIOUS MONONUCLEOSIS 1 0.0004
44 BLOOD BILIRUBIN INCREASED 11 0.0004
45 PLATELET DISORDER 1 0.0004
46 BLOOD CHLORIDE DECREASED 1 0.0004
47 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
48 JAUNDICE 10 0.0004
49 BLOOD SODIUM INCREASED 1 0.0004
50 BLOOD TEST ABNORMAL 5 0.0004
51 HAEMOGLOBIN DECREASED 36 0.0004
52 HYPERTONIC BLADDER 1 0.0003
53 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
54 INFUSION SITE REACTION 1 0.0003
55 DIZZINESS POSTURAL 3 0.0003
56 ACUTE HEPATIC FAILURE 4 0.0003
57 FULL BLOOD COUNT ABNORMAL 3 0.0003
58 MYELODYSPLASTIC SYNDROME 4 0.0003
59 ARTHRITIS BACTERIAL 1 0.0002
60 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
61 TENSION HEADACHE 1 0.0002
62 ANURIA 2 0.0002
63 INJECTION SITE INDURATION 3 0.0002
64 HAEMOGLOBIN INCREASED 1 0.0002
65 PNEUMONIA BACTERIAL 2 0.0002
66 THERAPY CHANGE 2 0.0002
67 MUCOUS STOOLS 1 0.0002
68 HEPATIC ENZYME ABNORMAL 1 0.0002
69 DYSPHORIA 1 0.0002
70 SERUM FERRITIN INCREASED 1 0.0002
71 HEPATIC FUNCTION ABNORMAL 7 0.0002
72 BLOOD GLUCOSE FLUCTUATION 2 0.0002
73 DEAFNESS UNILATERAL 1 0.0002
74 STREPTOCOCCAL INFECTION 1 0.0002
75 CHROMATURIA 4 0.0002
76 HERPES VIRUS INFECTION 1 0.0002
77 CHOLECYSTITIS 2 0.0002
78 CARDIAC PACEMAKER INSERTION 1 0.0002
79 CYTOPENIA 2 0.0002
80 CHOLANGITIS 1 0.0002
81 ILEUS 2 0.0002
82 PROCTALGIA 1 0.0002
83 RESPIRATORY TRACT INFECTION 4 0.0002
84 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
85 FULL BLOOD COUNT DECREASED 3 0.0001
86 BONE MARROW FAILURE 3 0.0001
87 JOINT EFFUSION 1 0.0001
88 HAIR GROWTH ABNORMAL 1 0.0001
89 PRODUCT SUPPLY ISSUE 1 0.0001
90 FAECES SOFT 1 0.0001
91 LIVER DISORDER 6 0.0001
92 IMMUNODEFICIENCY 2 0.0001
93 SUNBURN 1 0.0001
94 BRAIN FOG 2 0.0001
95 RHINITIS 1 0.0001
96 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
97 CIRCULATORY COLLAPSE 2 0.0001
98 PSEUDOMONAS INFECTION 1 0.0001
99 JOINT STIFFNESS 3 0.0001
100 HAEMOLYTIC ANAEMIA 1 0.0001
101 OSTEOMYELITIS 2 0.0001
102 UROSEPSIS 1 0.0001
103 CONJUNCTIVITIS 2 0.0001
104 DYSPNOEA EXERTIONAL 4 0.0001
105 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
106 HYPOCALCAEMIA 2 0.0001
107 HYPERCHOLESTEROLAEMIA 1 0.0001
108 HERNIA 2 0.0001
109 PLATELET COUNT DECREASED 11 0.0001
110 DYSSTASIA 3 0.0001
111 HEPATOMEGALY 1 0.0001
112 HYPOTHERMIA 1 0.0001
113 TOOTH ABSCESS 1 0.0001
114 RENAL PAIN 1 0.0001
115 LIVER FUNCTION TEST INCREASED 2 0.0001
116 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
117 HEPATOTOXICITY 2 0.0001
118 HAEMATURIA 3 0.0001
119 ANAEMIA 16 0.0001
120 NEURALGIA 2 0.0001
121 INFLUENZA 9 0.0001
122 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
123 CELLULITIS 4 0.0001
124 IMMUNE SYSTEM DISORDER 1 0.0001
125 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
126 EYE HAEMORRHAGE 1 0.0001
127 MALIGNANT MELANOMA 1 0.0001
128 GASTROENTERITIS 1 0.0001
129 COVID-19 12 0.0001
130 BLOOD POTASSIUM DECREASED 2 0.0001
131 HEPATIC FAILURE 2 0.0001
132 BASAL CELL CARCINOMA 1 0.0001
133 INFECTION 9 0.0001
134 RHINORRHOEA 4 0.0001
135 BLOOD PRESSURE DECREASED 4 0.0001
136 VIRAL INFECTION 2 0.0001
137 BLOOD UREA INCREASED 1 0.0001
138 RENAL IMPAIRMENT 5 0.0001
139 HEPATIC ENZYME INCREASED 4 0.0001
140 SPEECH DISORDER 3 0.0001
141 MUSCULOSKELETAL STIFFNESS 5 0.0001
142 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
143 DRUG ERUPTION 1 0.0001
144 SEPSIS 6 0.0001
145 HEPATIC STEATOSIS 1 0.0001
146 THROMBOCYTOPENIA 6 0.0001
147 URINARY TRACT INFECTION 9 0.0001
148 PNEUMONIA 17 0.0001
149 LOWER LIMB FRACTURE 1 0.0001
150 EAR PAIN 1 0.0001
151 DYSPHONIA 3 0.0001
152 HAEMATOCRIT DECREASED 1 0.0001
153 CATARACT 3 0.0001
154 FEEDING DISORDER 1 0.0000
155 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
156 EXPOSURE DURING PREGNANCY 3 0.0000
157 ROAD TRAFFIC ACCIDENT 2 0.0000
158 MOUTH ULCERATION 1 0.0000
159 RETCHING 1 0.0000
160 SKIN CANCER 1 0.0000
161 SEPTIC SHOCK 2 0.0000
162 ACUTE KIDNEY INJURY 7 0.0000
163 INJECTION SITE PRURITUS 3 0.0000
164 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
165 PANCREATITIS ACUTE 1 0.0000
166 NEPHROLITHIASIS 2 0.0000
167 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
168 LOCALISED INFECTION 1 0.0000
169 CEREBROVASCULAR ACCIDENT 7 0.0000
170 INTERSTITIAL LUNG DISEASE 2 0.0000
171 ATRIAL FIBRILLATION 4 0.0000
172 FLUID RETENTION 2 0.0000
173 INJECTION SITE SWELLING 3 0.0000
174 HYPOPHAGIA 1 0.0000
175 ERECTILE DYSFUNCTION 1 0.0000
176 PANCREATITIS 2 0.0000
177 INJECTION SITE HAEMORRHAGE 3 0.0000
178 FEAR 1 0.0000
179 NEUTROPENIA 5 0.0000
180 PALLOR 1 0.0000
181 MOOD ALTERED 1 0.0000
182 TREATMENT NONCOMPLIANCE 2 0.0000
183 DIVERTICULITIS 1 0.0000
184 FEELING COLD 1 0.0000
185 WOUND 1 0.0000
186 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
187 PAIN IN JAW 1 0.0000
188 RED BLOOD CELL COUNT DECREASED 1 0.0000
189 ANGINA PECTORIS 1 0.0000
190 HYPERSOMNIA 1 0.0000
191 GASTROINTESTINAL DISORDER 3 0.0000
192 EPILEPSY 1 0.0000
193 NASOPHARYNGITIS 6 0.0000
194 DRUG-INDUCED LIVER INJURY 1 0.0000
195 DRUG INTERACTION 5 0.0000
196 MOOD SWINGS 1 0.0000
197 METABOLIC ACIDOSIS 1 0.0000
198 CONTUSION 3 0.0000
199 NIGHT SWEATS 1 0.0000
200 FATIGUE 24 0.0000
201 DEEP VEIN THROMBOSIS 2 0.0000
202 CHOLELITHIASIS 1 0.0000
203 STAPHYLOCOCCAL INFECTION 1 0.0000
204 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
205 GAIT INABILITY 1 0.0000
206 TYPE 2 DIABETES MELLITUS 1 0.0000
207 ANGER 1 0.0000
208 ILLNESS 3 0.0000
209 MEMORY IMPAIRMENT 4 0.0000
210 THERAPY INTERRUPTED 2 0.0000
211 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
212 C-REACTIVE PROTEIN INCREASED 1 0.0000
213 DYSURIA 1 0.0000
214 EPISTAXIS 2 0.0000
215 ASTHENIA 10 0.0000
216 INTESTINAL OBSTRUCTION 1 0.0000
217 CHRONIC KIDNEY DISEASE 2 0.0000
218 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
219 PYREXIA 9 0.0000
220 BACK PAIN 6 0.0000
221 CHILLS 3 0.0000
222 DISORIENTATION 1 0.0000
223 ABORTION SPONTANEOUS 1 0.0000
224 CARDIAC FAILURE 2 0.0000
225 SOMNOLENCE 5 0.0000
226 OEDEMA PERIPHERAL 3 0.0000
227 CARDIAC ARREST 2 0.0000
228 INJECTION SITE ERYTHEMA 3 0.0000
229 RECTAL HAEMORRHAGE 1 0.0000
230 MALAISE 10 0.0000
231 TACHYCARDIA 2 0.0000
232 HEADACHE 14 0.0000
233 ABDOMINAL PAIN 5 0.0000
234 BLOOD CHOLESTEROL INCREASED 1 0.0000
235 VOMITING 10 0.0000
236 PRODUCTIVE COUGH 1 0.0000
237 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
238 PRODUCT DOSE OMISSION ISSUE 6 0.0000
239 DIARRHOEA 13 0.0000
240 CONDITION AGGRAVATED 6 0.0000
241 SINUSITIS 2 0.0000
242 OFF LABEL USE 17 0.0000
243 HAEMORRHAGE 2 0.0000
244 MUSCULOSKELETAL PAIN 1 0.0000
245 DISTURBANCE IN ATTENTION 1 0.0000
246 HAEMATOCHEZIA 1 0.0000
247 ANAPHYLACTIC REACTION 1 0.0000
248 COUGH 5 0.0000
249 EYE IRRITATION 1 0.0000
250 SEIZURE 2 0.0000
251 DECREASED APPETITE 4 0.0000
252 BONE PAIN 1 0.0000
253 SURGERY 1 0.0000
254 FEELING ABNORMAL 4 0.0000
255 MUSCLE SPASMS 3 0.0000
256 LOSS OF CONSCIOUSNESS 2 0.0000
257 INFUSION RELATED REACTION 1 0.0000
258 DRY SKIN 2 0.0000
259 SLEEP DISORDER 1 0.0000
260 HYPERTENSION 3 0.0000
261 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
262 RESPIRATORY FAILURE 1 0.0000
263 PAIN IN EXTREMITY 4 0.0000
264 BRONCHITIS 1 0.0000
265 PRURITUS 5 0.0000
266 DRUG INEFFECTIVE 17 0.0000
267 ARTHRITIS 1 0.0000
268 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
269 DRY MOUTH 1 0.0000
270 INFLUENZA LIKE ILLNESS 1 0.0000
271 ARTHRALGIA 5 0.0000
272 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
273 BALANCE DISORDER 1 0.0000
274 NAUSEA 9 0.0000
275 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
276 DEVICE ISSUE 1 0.0000
277 SUICIDAL IDEATION 1 0.0000
278 CHEST PAIN 2 0.0000
279 CARDIAC DISORDER 1 0.0000
280 DYSPHAGIA 1 0.0000
281 MIGRAINE 1 0.0000
282 DEATH 9 0.0000
283 DYSPEPSIA 1 0.0000
284 CHEST DISCOMFORT 1 0.0000
285 ABDOMINAL PAIN UPPER 2 0.0000
286 CONSTIPATION 2 0.0000
287 WEIGHT INCREASED 2 0.0000
288 DYSPNOEA 5 0.0000
289 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
290 PALPITATIONS 1 0.0000
291 DISEASE PROGRESSION 1 0.0000
292 EMOTIONAL DISTRESS 1 0.0000
293 VISUAL IMPAIRMENT 1 0.0000
294 DIZZINESS 4 0.0000
295 RENAL FAILURE 1 0.0000
296 INSOMNIA 2 0.0000
297 DEHYDRATION 1 0.0000
298 VISION BLURRED 1 0.0000
299 WEIGHT DECREASED 2 0.0000
300 HYPOAESTHESIA 1 0.0000
301 BLOOD PRESSURE INCREASED 1 0.0000
302 HOSPITALISATION 1 0.0000
303 PARAESTHESIA 1 0.0000
304 CONFUSIONAL STATE 1 0.0000
305 TREMOR 1 0.0000
306 FALL 2 0.0000
307 MYALGIA 1 0.0000
308 NO ADVERSE EVENT 1 0.0000
309 HYPERSENSITIVITY 1 0.0000
310 GAIT DISTURBANCE 1 0.0000
311 HYPOTENSION 1 0.0000
312 PAIN 3 0.0000
313 ANXIETY 1 0.0000